HIV disease progression by hormonal contraceptive method: Secondary analysis of a randomized trial

AIDS

Volumn 23, Issue 11, 2009, Pages 1377-1382

  Stringer, Elizabeth M ^a,b   Levy, Jens ^c   Sinkala, Moses ^d   Chi, Benjamin H ^a,b   Matongo, Inutu ^a   Chintu, Namwinga ^a   Stringer, Jeffrey S A ^a,b  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Catholic Medical Mission Board   (Zambia)

Author keywords

Disease progression; Family planning; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; COPPER INTRAUTERINE DEVICE; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE COURSE; EDUCATION; FAMILY PLANNING; FEMALE; FOLLOW UP; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VERTICAL TRANSMISSION; ZAMBIA;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CONTRACEPTION BEHAVIOR; CONTRACEPTIVES, ORAL, HORMONAL; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTRAUTERINE DEVICES; PREGNANCY; PREGNANCY, UNPLANNED; YOUNG ADULT;

EID: 68449091991     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832cbca8     Document Type: Article

References (21)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization. Report on the global HIV/AIDS epidemic 2007. Geneva, Switzerland: UNAIDS; 2007.
2. Grimes DA, Benson J, Singh S, Romero M, Ganatra B, Okonofua FE, Shah IH. Unsafe abortions: the preventable pandemic. Lancet 2006; 368:1908-1919.
3. Singh S, Darroch JE, Vlassoff M, Nadeau J. Adding it up: the benefits of investing in sexual and reproductive healthcare. New York: The Allan Guttmacher Institute; 2003.
4. UNAIDS. Report on the global HIV/'AIDS epidemic: 4th global report. Geneva, Switzerland: UNAIDS; 2004.
5. Seiber EE, Bertrand JT, Sullivan TM. Changes in contraceptive method mix in developing countries. Int Fam Plan Perspect 2007; 33:117-123.
6. Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, et al. A randomized trial of the intrauterine contraceptive device (IUD) versus hormonal contraception in HIV-1-infected women. Am J. Obstet Cynecol 2007; 197:144.e1-144.e8.
7. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996; 2:1084-1089.
8. Baeten JM, Lavreys L, Sagar M, Kreiss JK, Richardson BA, Chohan B, et al. Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort. J Acquir Immune Defic Syndr 2005; 38 (Suppl 1):S18-S21.
9. Rabkin M, El Sadr W. Saving mothers, saving families: the MTCT-Plus initiative - case study. Perspectives and practice in antiretroviral treatment. Geneva, Switzerland: WHO; 2003. p. 13.
10. Trunova N, Tsai L, Tung S, Schneider E, Harouse J, Gettie A, et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology 2006; 352:169-177.
11. Lavreys L, Baeten JM, Chohan V, McClelland RS, Hassan WM, Richardson BA, et al. Higher set point plasma viral load and more-severe acute HIV type (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis 2006; 42:1333-1339.
12. Cejtin HE, Jacobson L, Springer G, Watts D, Levine A, Green-blatt R, et al. Effect of hormonal contraceptive use on plasma HIV-1 RNA levels among HIV-infected women. AIDS 2003; 17:1702-1704.
13. Richardson BA, Otieno PA, Mbori-Ngacha D, Overbaugh J, Farquhar C, John-Stewart GC. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women. AIDS 2007; 21:749-753.
14. Danel L, Vincent C, Rousset F, Klein B, Bataille R, Flacher M, et al. Estrogen and progesterone receptors in some human myeloma cell lines and murine hybridomas. J Steroid Biochem 1988; 30:363-367.
15. Pasanen S, Ylikomi T, Palojoki E, Syvala H, Pelto-Huikko M, Tuohimaa P. Progesterone receptor in chicken bursa of Fabri-cius and thymus: evidence for expression in B-lymphocytes. Mol Cell Endocrinol 1998; 141:119-128.
16. Enomoto LM, Kloberdanz KJ, Mack DG, Elizabeth D, Weinberg A. Ex vivo effect of estrogen and progesterone compared with dexamethasone on cell-mediated immunity of HIV-infected and uninfected subjects. J Acquir Immune Defic Syndr 2007;45:137-143.
17. Maret A, Coudert JD, Garidou L, Foucras G, Gourdy P, Krust A, et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hemaotpoietic cells. Eur J Immunol 2003; 33:512-521.
18. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003; 101:2711-2720.
19. Appay V, Almeida JR, Sauce D, Autran B, Papagno L. Accelerated immune senescence and HIV-1 infection. Exp Cerontol 2007; 42:432-437.
20. Nilsson J, Boasso A, Velilla PA, Zhang R, Vaccari M, Franchini G, et al. HIV-1-driven regulatory T-cell accumulation in lym-phoid tissues is associated with disease progression in HIV/AIDS. Blood 2006; 108:3808-3817.
21. WHO, UNICEF, UNFPA, The World Bank. Maternal Mortality in 2005. Geneva, Switzerland: WHO; 2007.